Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04149964 · ClinicalTrials.gov registry record · Phase 4

Postoperative Pain Control in Septum and Sinus Surgery

A Phase 4 study of Postoperative Pain and Sinus Surgery, sponsored by Corewell Health East.

Completed
Registry status
Phase 4
Development phase
65
Enrollment target
1
Study location

NCT04149964: Completed Phase 4 study of Postoperative Pain and Sinus Surgery, sponsored by Corewell Health East.

NCT04149964 is a Phase 4 study of Postoperative Pain and Sinus Surgery that has completed, run by Corewell Health East. The registered enrollment target is 65 participants, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04149964, a Phase 4 study of Postoperative Pain and Sinus Surgery, has completed, sponsored by Corewell Health East.

COMPLETED
Registry status
Phase 4
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate if the use of acetaminophen round the clock (scheduled doses) will lead to less opiate use in the first week post-operative (after surgery) in sinus/septum surgery patients. Participants will be randomized like a flip of a coin to either the standard of care pain treatment of acetaminophen 325 mg as needed for pain plus opiates (acetaminophen/hydrocodone) as needed for breakthrough pain; OR to the study arm of acetaminophen 650 mg every 6 hours plus opiates (Oxycodone)as needed for breakthrough pain.

Primary Outcome

Number of doses of opiates (narcotic) pain medication participants took for breakthrough pain in the first postoperative week.

Interventions

  • DRUG OxyCODONE 5 mg Oral Tablet
  • DRUG Acetaminophen 650 mg Oral Tablet
  • DRUG Acetaminophen 325 mg Oral Tablet
  • DRUG Acetaminophen/Hydrocodone 325 mg/7.5 mg oral tablet

Study Locations (1)

Michigan

  • Beaumont Hospital - Farmington Hills

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2019-11-27
Est. Completion 2022-09-21
Phase Phase 4
Corewell Health East

106 total trials

What the finished NCT04149964 record still lists

NCT04149964 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (72% lower).

The record links to 2 conditions, with Postoperative Pain appearing as the primary indexed condition, and to 4 interventions - of which OxyCODONE 5 mg Oral Tablet is the first listed.

NCT04149964 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT04149964 about?

NCT04149964 is a clinical study titled "Postoperative Pain Control in Septum and Sinus Surgery". This study will evaluate if the use of acetaminophen round the clock (scheduled doses) will lead to less opiate use in the first week post-operative (after surgery) in sinus/septum surgery patients. Participants will be randomized like a flip of a coin to either the standard of care pain treatment o...

What is the current status of trial NCT04149964?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 65 participants. The study started on 2019-11-27. Estimated completion is 2022-09-21.

What conditions does trial NCT04149964 study?

This clinical trial studies the following conditions: Postoperative Pain, Sinus Surgery.

What interventions are being tested in trial NCT04149964?

The interventions under investigation include: OxyCODONE 5 mg Oral Tablet (DRUG), Acetaminophen 650 mg Oral Tablet (DRUG), Acetaminophen 325 mg Oral Tablet (DRUG), Acetaminophen/Hydrocodone 325 mg/7.5 mg oral tablet (DRUG).

Who is sponsoring clinical trial NCT04149964?

This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04149964 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04149964's enrollment target sits among peer trials

65 94th of 120 higher than 27 of 120 other Postoperative Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03366116 · 65 participants · Phase 1

    5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

  • NCT03603730 · 65 participants · NA

    Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

  • NCT03796559 · 65 participants · NA

    Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

  • NCT03993106 · 65 participants · Phase 2

    A Study of sEphB4-HSA in Kaposi Sarcoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04149964, the US trial registry maintained by the National Library of Medicine. NCT04149964 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.